By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Avraham Pharmaceuticals Ltd. 



Tel Aviv      Israel
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Avraham Pharmaceuticals Ltd. Announces Successful Second Interim Results In Phase IIb Study Of Ladostigil For The Treatment Of Mild Cognitive Impairment 7/28/2015 10:52:40 AM
Avraham Pharmaceuticals Ltd. Raises $4.5 Million In Additional Investment Led By Yissum 9/17/2014 9:14:59 AM
Avraham Pharmaceuticals Ltd. Announces Successful Interim Results In Phase 2b Study Of Ladostigil For The Treatment Of MCI 7/8/2014 8:30:28 AM
Avraham Pharmaceuticals Ltd. Closes a $6 Million Investment 2/21/2013 7:17:28 AM
Avraham Pharmaceuticals Ltd. Announces Commencement of a Phase 2 Study of Ladostigil for the Treatment of MCI 5/17/2012 9:59:31 AM
Avraham Pharmaceuticals Ltd. Receives Orphan Medicinal Product Designation for Tivozanib for the Treatment of Renal Cell Carcinoma by the European Medicines Evaluation Agency 6/24/2010 6:24:33 AM
Yissum Ltd., Pontifax, and Clal Biotechnology Industries Invest $9 Million in Avraham Pharmaceuticals Ltd. to Pursue a Phase IIb Clinical Trial of Ladostigil, a Novel Drug for Treatment of Alzheimer's Disease 4/14/2010 6:40:38 AM
//-->